News & Updates
Showing Multidisciplinary articles
Showing
Nutritional status predicts treatment tolerability, mortality risk in IPF patients
The nutritional status of patients with idiopathic pulmonary fibrosis (IPF) has a significant impact on both treatment and outcome, suggests a study, noting that assessing the nutritional status offers helpful information for managing these individuals.
Camrelizumab plus chemo combo beneficial in Asian patients with advanced NSCLC
Adding camrelizumab to platinum-based chemotherapy in the neoadjuvant treatment setting appears to improve the rate of pathologic complete response (pCR) in Asian patients with stage IIIA or IIIB non–small cell lung cancer (NSCLC), with manageable toxicity, according to data from the phase II TD-FOREKNOW study.
Fosaprepitant dosing frequency makes no difference in CCRT-induced nausea, vomiting prevention
For patients undergoing concurrent chemoradiotherapy (CCRT), treatment with either weekly or every-3-weeks fosaprepitant helps reduce nausea and vomiting caused by CCRT, with no difference in the effect, as reported in a study.
Impaired RV function, pulmonary coupling tied to hospitalizations, death in HFpEF patients
Worsening right ventricular (RV) function normally occurs in patients with heart failure and preserved left ventricular ejection fraction (HFpEF) and, along with its ratio to pulmonary pressure, is predictive of a higher risk of HF hospitalizations and cardiovascular death, reports a study.
Change in gait speed predicts hospitalization, death in IPF patients
A considerable decline of >0.07 m/s in 4-metre gait speed (4MGS) over 6 months is associated with a higher risk of all-cause, nonelective hospitalization or death over the next 6 months in patients with a newly diagnosed idiopathic pulmonary fibrosis (IPF), suggests a study.
